Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,000
Closed -$258K 348
2025
Q2
$258K Sell
1,000
-127
-11% -$30.3K 0.02% 282
2025
Q1
$252K Sell
1,127
-40
-3% -$9.34K 0.02% 282
2024
Q4
$267K Hold
1,167
0.02% 273
2024
Q3
$285K Sell
1,167
-250
-18% -$55.9K 0.02% 265
2024
Q2
$271K Sell
1,417
-100
-7% -$20.3K 0.02% 266
2024
Q1
$300K Hold
1,517
0.02% 258
2023
Q4
$261K Sell
1,517
-150
-9% -$23K 0.02% 245
2023
Q3
$246K Hold
1,667
0.02% 250
2023
Q2
$364K Hold
1,667
0.03% 217
2023
Q1
$365K Hold
1,667
0.03% 210
2022
Q4
$347K Hold
1,667
0.03% 209
2022
Q3
$364K Hold
1,667
0.03% 214
2022
Q2
$349K Hold
1,667
0.03% 215
2022
Q1
$404K Hold
1,667
0.03% 222
2021
Q4
$434K Hold
1,667
0.03% 219
2021
Q3
$439K Buy
1,667
+2
+0.1% +$547 0.03% 214
2021
Q2
$410K Hold
1,665
0.03% 220
2021
Q1
$323K Hold
1,665
0.03% 224
2020
Q4
$354K Hold
1,665
0.03% 209
2020
Q3
$285K Hold
1,665
0.03% 208
2020
Q2
$320K Hold
1,665
0.04% 199
2020
Q1
$245K Buy
1,665
+150
+10% +$23.9K 0.03% 204
2019
Q4
$235K Sell
1,515
-65
-4% -$9.37K 0.02% 227
2019
Q3
$213K Buy
+1,580
New +$207K 0.02% 227

Other funds holding RMD

Patten & Patten's RMD Position: Q3 2025 in Review

Patten & Patten sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,000 shares — an estimated $258K sold.

Patten & Patten first reported a position in RMD in Q3 2019 and held it in 24 quarters. The position peaked at $439K in Q3 2021. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Patten & Patten reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Patten & Patten sold 1,000 ResMed shares in Q3 2025, an estimated $258K.
  • Patten & Patten first reported a position in ResMed in Q3 2019 and held it in 24 quarters.
  • Patten & Patten's ResMed position peaked at $439K in Q3 2021.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Patten & Patten's 13F filing for Q3 2025, filed 31 Oct 2025.